What is McKesson's u.s. pharmaceutical — total other segment expense, net?

McKesson (MCK) reported u.s. pharmaceutical — total other segment expense, net of $89.23B in Q2 2025.

What does u.s. pharmaceutical — total other segment expense, net mean?

The net total of miscellaneous operating expenses incurred by the U.S. Pharmaceutical segment.

Discontinued — last reported Q2 '25

Business Segments · Total other segment expense, net

U.S. Pharmaceutical — Total other segment expense, net

McKesson U.S. Pharmaceutical — Total other segment expense, net increased by 25.8% to $89.23B in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 25.8%, from $70.93B to $89.23B. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment

CategoryEfficiency

SignalLower is better

VolatilityStable

First reportedQ1 2023

Last reportedQ2 2025Aug 6, 2025

Rolls up toSegment Reporting, Other Segment Item, Amount

How to read this metric

A decrease in net expenses relative to revenue indicates improved operational efficiency and cost management.

Detailed definition

Includes all net operating expenses for the U.S. Pharmaceutical segment that are not categorized as cost of goods sold o...

Peer comparison

Standard operating expense metric used across all large-scale distribution companies.

Metric ID: mck_segment_u_s_pharmaceutical_total_other_segment_expense_net

Historical Data

6 periods

	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q2 '24	Q2 '25
Value	$59.35B	$59.35B	$59.35B	$59.35B	$70.93B	$89.23B
QoQ Change	—	+0.0%	+0.0%	+0.0%	+19.5%	+25.8%
YoY Change	—	—	—	—	+19.5%	+25.8%

Range$59.35B – $89.23B

CAGR+38.6%

Avg YoY Growth+22.7%

Median YoY Growth+22.7%

Current Streak5+ quarters growth

Similar Metrics at Other Companies

Labcorp HoldingsLH View metric

ZoetisZTS View metric

Vertex PharmaceuticalsVRTX View metric

CVS HealthCVS View metric

Becton, Dickinson and CompanyBDX View metric

ViatrisVTRS View metric

Frequently Asked Questions

What is McKesson's u.s. pharmaceutical — total other segment expense, net?: McKesson (MCK) reported u.s. pharmaceutical — total other segment expense, net of $89.23B in Q2 2025.
How has McKesson's u.s. pharmaceutical — total other segment expense, net changed year-over-year?: McKesson's u.s. pharmaceutical — total other segment expense, net increased by 25.8% year-over-year, from $70.93B to $89.23B.
What does u.s. pharmaceutical — total other segment expense, net mean?: The net total of miscellaneous operating expenses incurred by the U.S. Pharmaceutical segment.